Pulmonary Embolism and Increased Levels of d-Dimer in Patients with Coronavirus Disease.
Acute Disease
Aged
Antibodies, Monoclonal, Humanized
/ therapeutic use
Anticoagulants
/ therapeutic use
Betacoronavirus
/ drug effects
Biomarkers
/ blood
COVID-19
COVID-19 Testing
Clinical Laboratory Techniques
/ methods
Coronavirus Infections
/ complications
Cytokine Release Syndrome
/ complications
Enoxaparin
/ therapeutic use
Female
Fibrin Fibrinogen Degradation Products
/ metabolism
Humans
Hypoxia
/ complications
Male
Methylprednisolone Hemisuccinate
/ therapeutic use
Middle Aged
Pandemics
Pneumonia, Viral
/ complications
Pulmonary Embolism
/ complications
Rivaroxaban
/ therapeutic use
SARS-CoV-2
Tomography, X-Ray Computed
Treatment Outcome
COVID-19
SARS-CoV-2
coronavirus disease
d-dimer
deep vein thrombosis
hypercoagulability
prophylaxis
pulmonary embolism
respiratory infections
sequelae
severe acute respiratory syndrome coronavirus 2
thromboembolic
viruses
Journal
Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
pubmed:
30
4
2020
medline:
30
7
2020
entrez:
30
4
2020
Statut:
ppublish
Résumé
We report 3 patients with coronavirus disease who had a decline in respiratory status during their hospital course that responded well to intravenous steroids and interleukin-6 receptor antagonist therapy. These patients later showed development of persistent hypoxia with increased levels of d-dimer levels and were given a diagnosis of pulmonary embolisms.
Identifiants
pubmed: 32348233
doi: 10.3201/eid2608.201477
pmc: PMC7392455
doi:
Substances chimiques
Antibodies, Monoclonal, Humanized
0
Anticoagulants
0
Biomarkers
0
Enoxaparin
0
Fibrin Fibrinogen Degradation Products
0
fibrin fragment D
0
Methylprednisolone Hemisuccinate
5GMR90S4KN
Rivaroxaban
9NDF7JZ4M3
tocilizumab
I031V2H011
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1941-1943Commentaires et corrections
Type : CommentIn
Références
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Eur Heart J. 2020 May 14;41(19):1858
pubmed: 32227120
J Nucl Med. 2020 May;61(5):630-631
pubmed: 32238427
J Thromb Haemost. 2020 May;18(5):1094-1099
pubmed: 32220112